Aleva Neurotherapeutics is a pioneering company based in Lausanne, Switzerland, specializing in advanced neurostimulation technologies. The organization focuses on developing innovative solutions for neurological disorders, utilizing cutting-edge research in neuroengineering and biomedicine. Aleva's expertise lies in creating targeted therapies that aim to improve patient outcomes through precise modulation of neural circuits, positioning the company at the forefront of the medical device industry in the realm of neuromodulation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#24 in Lausanne

#805 in Switzerland

#39,959 in the World

Lausanne, Switzerland

Aleva Neurotherapeutics

Forward Citations = 139

11 inventors:

Andre Mercanzini (12 out of 20 patents)

Alain Jordan (10 out of 17 patents)

Alain Dransart (8 out of 8 patents)

4. Marc Boers (7 out of 9 patents)

5. Alexandre Michalis (7 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aleva Neurotherapeutics. Retrieved from https://idiyas.com/company/aleva-neurotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]